This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (21)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

A Multicenter Study

JAMA. 1986;256(20):2829-2834.

Abstract
Lovastatin (mevinolin), a potent inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, was investigated in a double-blind, placebo-controlled multicenter study of 101 patients with nonfamilial primary hypercholesterolemia. Dosages varied from 10 to 80 mg/d in single or divided doses. Patients receiving 40 mg twice a day experienced mean total and low-density lipoprotein cholesterol reductions of 32% and 39%, respectively. High-density lipoprotein cholesterol levels tended to rise slightly and plasma triglyceride levels were moderately decreased. Adverse effects attributable to lovastatin were infrequent and no patient was withdrawn from therapy. In this study, lovastatin was a well tolerated and effective agent for the treatment of nonfamilial hypercholesterolemia.

(JAMA 1986;256:2829-2834)

Footnotes
From the Lovastatin Study Group II.

Reprint requests to Merck Sharp & Dohme Research Laboratories, PO Box 2000, Rahway, NJ 07065-0914 (Jonathan A Tobert, MB, PhD).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Efficacy and Safety of Lovastatin Therapy in Adolescent Girls With Heterozygous Familial Hypercholesterolemia
Clauss et al.
Pediatrics 2005;116:682-688.
ABSTRACT | FULL TEXT  

Efficacy of Extended-Release Niacin With Lovastatin for Hypercholesterolemia: Assessing All Reasonable Doses With Innovative Surface Graph Analysis
Insull et al.
Arch Intern Med 2004;164:1121-1127.
ABSTRACT | FULL TEXT  

Effects of Atorvastatin on the Intracellular Stability and Secretion of Apolipoprotein B in HepG2 Cells
Mohammadi et al.
Arterioscler. Thromb. Vasc. Bio. 1998;18:783-793.
ABSTRACT | FULL TEXT  

Treating Hyperlipidemia for the Primary Prevention of Coronary Disease: Are Higher Dosages of Lovastatin Cost-effective?
Perreault et al.
Arch Intern Med 1998;158:375-381.
ABSTRACT | FULL TEXT  

Lovastatin Decreases De Novo Cholesterol Synthesis and LDL Apo B-100 Production Rates in Combined-Hyperlipidemic Males
Cuchel et al.
Arterioscler. Thromb. Vasc. Bio. 1997;17:1910-1917.
ABSTRACT | FULL TEXT  

Cholesterol-Reduction Intervention Study (CRIS) A Randomized Trial to Assess Effectiveness and Costs in Clinical Practice
Oster et al.
Arch Intern Med 1996;156:731-739.
ABSTRACT  

A Randomized Multicenter Trial Comparing the Efficacy of Simvastatin and Fluvastatin
Illingworth et al.
J CARDIOVASC PHARMACOL THER 1996;1:23-29.
ABSTRACT  

Nicotinic Acid as a Lipoprotein-Altering Agent: Therapy Directed by the Primary Physician
Probstfield and Hunninghake
Arch Intern Med 1994;154:1557-1559.
ABSTRACT  

Combination Drug Therapy for Hypercholesterolemia: The Trade-off Between Cost and Simplicity
Heudebert et al.
Arch Intern Med 1993;153:1828-1837.
ABSTRACT  

High-Molecular-Weight Hydroxypropylmethylcellulose: A Cholesterol-Lowering Agent
Dressman et al.
Arch Intern Med 1993;153:1345-NP.
ABSTRACT  

Lovastatin 5-Year Safety and Efficacy Study
Lovastatin Study Groups I Through IV
Arch Intern Med 1993;153:1079-1087.
ABSTRACT  

The Efficacy of Intensive Dietary Therapy Alone or Combined with Lovastatin in Outpatients with Hypercholesterolemia
Hunninghake et al.
NEJM 1993;328:1213-1219.
ABSTRACT | FULL TEXT  

The Effect of Pravastatin on Plasma Lipoprotein and Apolipoprotein Levels in Primary Hypercholesterolemia
Rubenfire et al.
Arch Intern Med 1991;151:2234-2240.
ABSTRACT  

Cost-effectiveness of HMG-CoA Reductase Inhibition for Primary and Secondary Prevention of Coronary Heart Disease
Goldman et al.
JAMA 1991;265:1145-1151.
ABSTRACT  

Lovastatin Efficacy in Reducing Low-Density Lipoprotein Cholesterol Levels on High- vs Low-Fat Diets
Cobb et al.
JAMA 1991;265:997-1001.
ABSTRACT  

Expanded Clinical Evaluation of Lovastatin (EXCEL) Study Results: I. Efficacy in Modifying Plasma Lipoproteins and Adverse Event Profile in 8245 Patients With Moderate Hypercholesterolemia
Bradford et al.
Arch Intern Med 1991;151:43-49.
ABSTRACT  

Pravastatin vs Gemfibrozil in the Treatment of Primary Hypercholesterolemia: The Italian Multicenter Pravastatin Study I
Crepaldi et al.
Arch Intern Med 1991;151:146-152.
ABSTRACT  

Reducing High Blood Cholesterol Level With Drugs: Cost-effectiveness of Pharmacologic Management
Schulman et al.
JAMA 1990;264:3025-3033.
ABSTRACT  

Lovastatin: Warfarin Interaction
Ahmad
Arch Intern Med 1990;150:2407-2407.
ABSTRACT  

Effectiveness of Low-Dose Lovastatin in Lowering Serum Cholesterol: Experience With 56 Patients
Bates et al.
Arch Intern Med 1990;150:1947-1950.
ABSTRACT  

Within-Person Fluctuations of Serum Cholesterol and Lipoproteins
Mogadam et al.
Arch Intern Med 1990;150:1645-1648.
ABSTRACT  

Hypercholesterolemia in Elderly Persons: Resolving the Treatment Dilemma
Denke and Grundy
ANN INTERN MED 1990;112:780-792.
ABSTRACT  

Effects of Simvastatin and Cholestyramine in Familial and Nonfamilial Hypercholesterolemia
Stein et al.
Arch Intern Med 1990;150:341-345.
ABSTRACT  

Rhabdomyolysis and Acute Renal Failure Induced by Combination Lovastatin and Gemfibrozil Therapy
Marais and Larson
ANN INTERN MED 1990;112:228-230.
ABSTRACT  

Comparison of Lovastatin and Gemfibrozil in Normolipidemic Patients With Hypoalphalipoproteinemia
Vega and Grundy
JAMA 1989;262:3148-3153.
ABSTRACT  

Screening Asymptomatic Adults for Cardiac Risk Factors: The Serum Cholesterol Level
Garber et al.
ANN INTERN MED 1989;110:622-639.
ABSTRACT  

Lovastatin vs Cholestyramine Therapy for Primary Hypercholesterolemia-Reply
Tobert
JAMA 1988;260:3591-3591.
ABSTRACT  

Lovastatin and Rhabdomyolysis
Ayanian et al.
ANN INTERN MED 1988;109:682-683.
ABSTRACT  

Evaluation and Treatment of Hypercholesterolemia
Talbert
Journal of Pharmacy Practice 1988;1:100-110.
 

A Multicenter Comparison of Lovastatin and Cholestyramine Therapy for Severe Primary Hypercholesterolemia
The Lovastatin Study Group III
JAMA 1988;260:359-366.
ABSTRACT  

Rhabdomyolysis and Renal Injury With Lovastatin Use: Report of Two Cases in Cardiac Transplant Recipients
Corpier et al.
JAMA 1988;260:239-241.
ABSTRACT  

Give Diet a Chance in Lowering Cholesterol Levels
Ellison
Arch Intern Med 1988;148:1017-1019.
ABSTRACT  

Lovastatin: Follow-up Ophthalmologic Data
Hunninghake et al.
JAMA 1988;259:354-355.
ABSTRACT  

Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
The Expert Panel et al.
Arch Intern Med 1988;148:36-69.
ABSTRACT  

Change in Physician Perspective on Cholesterol and Heart Disease: Results From Two National Surveys
Schucker et al.
JAMA 1987;258:3521-3526.
ABSTRACT  

3-Hydroxy-3-Methylglutaryl--Coenzyme A Reductase Inhibitors in the Treatment of Hypercholesterolemia
Hoeg and Brewer
JAMA 1987;258:3532-3536.
ABSTRACT  

Lovastatin (Mevinolin) in the Treatment of Heterozygous Familial Hypercholesterolemia: A Multicenter Study
HAVEL et al.
ANN INTERN MED 1987;107:609-615.
ABSTRACT  

3-Hydroxy-3-methylglutaryl Coenzyme A (HMG-CoA) Reductase Inhibitors: A New Class of Cholesterol-Lowering Agents
GORDON and RIFKIND
ANN INTERN MED 1987;107:759-761.
ABSTRACT  

The Effect of CS-514 on Serum Lipids and Apolipoproteins in Hypercholesterolemic Subjects
Nakaya et al.
JAMA 1987;257:3088-3093.
ABSTRACT  

Inhibitors of Cholesterol Synthesis and Cataracts
Cenedella
JAMA 1987;257:1602-1602.
ABSTRACT  

Familial Hypercholesterolemia: There Is a Need for Early Detection and Treatment
Bilheimer
JAMA 1987;257:69-70.
ABSTRACT